Visual side effects possibly associated with viagra

Journal of Toxicology - Cutaneous and Ocular Toxicology

Volumn 19, Issue 1, 2000, Pages 21-25

  Fraunfelder, F T ^a,c   Laties, Alan M ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b WILLS EYE HOSPITAL   (United States)

^c or 97239 4197   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; SILDENAFIL;

ADULT; AGED; ARTICLE; COLOR VISION; CONJUNCTIVA DISEASE; ERECTILE DYSFUNCTION; HUMAN; MALE; PERCEPTION DISORDER; RETINA; VISUAL DISORDER; VISUAL IMPAIRMENT;

EID: 0033999530     PISSN: 07313829     EISSN: None     Source Type: Journal    
DOI: 10.3109/15569520009051474     Document Type: Article

References (7)

1. J.A. Beavo, Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms, Physiol. Rev. 75:725-748, 1995.
2. S.A. Ballard, C.J. Gingell, K. Tang, L.A. Turner, M.E. Price, and A.M. Naylor, Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes, J. Urol.159:2164-2171, 1998.
3. H. Goldstein, T.F. Lue, H. Padma-Nathan, R.C. Rosen, W.D. Steers, and P.A. Wicker, Oral sildenafil in the treatment of erectile dysfunction, N. Engl. J. Med. 338:1397-1494, 1998.
4. S. Moncada and A. Higgs: The L-arginine-nitric oxide pathway, N. Engl. J. Med. 329:2002-2012, 1993.
5. A.L. Burnett, Nitric oxide in the penis: Physiology and pathology, J. Urol. 157:320-324, 1997.
6. A. Laties, P. Ellis, N. Koppiker, A. Pattat, and B. Stuckey, Visual function testing in patients and healthy volunteers receiving Viagra®, Ophthal. Rev. Abstract 3345, 1998.
7. R.M. Wallis, D. Leishman, L. Pullman, P. Graepel, and R. Heywood, Effects of sildenafil on retinal histopathology and electroretinogram (ERG) in dogs, Ophthal. Rev. abstract 341, 1998.